Moderna announced promising results for its coronavirus vaccine on Monday, saying it plans to apply for emergency use authorization in the United States and Europe.In early January, when the novel coronavirus was still a mysterious disease in China, the U.S.
biotech company started chasing a potential vaccine. Moderna says coronavirus vaccine 94.1% effective, requests U.S., Europe approval Moderna CEO Stéphane Bancel said he read an article about the coronavirus in Wuhan, which was quickly spreading throughout the region at the time.Bancel said he immediately reached out to the Vaccine Research Center at the U.S.’ National Institutes of Health (NIH), according to Boston Magazine.